Show simple item record

dc.contributor.authorLorenzo Rego, Irenees-ES
dc.date.accessioned2024-04-02T14:59:52Z
dc.date.available2024-04-02T14:59:52Z
dc.date.issued2024-03-01es_ES
dc.identifier.issn1747-1532es_ES
dc.identifier.urihttps://doi.org/10.1093/jiplp/jpad115es_ES
dc.identifier.urihttp://hdl.handle.net/11531/87936
dc.descriptionArtículos en revistases_ES
dc.description.abstract.es-ES
dc.description.abstractEncouraging innovation by rewarding pharmaceutical patent holders is a key to societal progress, given mandatory disclosure and adequate reimbursement. Following debate on fair prices from a competition law perspective, the recent Health Trade Assessment Regulation provides Member States with a harmonized tool to help them set prices in a more sustainable way. • Tis article discusses the extent to which the Regulation will provide comprehensive access to healthcare as an expression of patient welfare, framing the debate in terms of sustainability.en-GB
dc.format.mimetypeapplication/pdfes_ES
dc.language.isoen-GBes_ES
dc.rightses_ES
dc.rights.uries_ES
dc.sourceRevista: Journal of Intellectual Property Law Practice, Periodo: 1, Volumen: 19, Número: 3, Página inicial: 250, Página final: 255es_ES
dc.titleTowards patient welfare-centred pharmaceutical patents. A sustainable perspectivees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.description.versioninfo:eu-repo/semantics/publishedVersiones_ES
dc.rights.holderPolítica editoriales_ES
dc.rights.accessRightsinfo:eu-repo/semantics/restrictedAccesses_ES
dc.keywords.es-ES
dc.keywordsInnovation Pharmaceutical Patent holders Regulation Healthcareen-GB


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • Artículos
    Artículos de revista, capítulos de libro y contribuciones en congresos publicadas.

Show simple item record